SUPPLEMENTARY INFORMATION
|
|
- Kathryn Hill
- 5 years ago
- Views:
Transcription
1 doi: /nature15260 Supplementary Data 1: Gene expression in individual basal/stem, luminal, and luminal progenitor cells. Box plots show expression levels for each gene from the 49-gene differentiation signature in individual cells. P-values and fold change for each gene are shown in Supplementary Table 2. Black dots, single cells; red dots, single cells with no expression. B, basal; LP, luminal progenitor; L, luminal. Supplementary Data 2: Full heatmaps showing unsupervised hierarchical clustering 1
2 2 HCI-001 KIT NOTCH3 GATA3 CD10 NOTCH4 SNAI2 CDK1 BCL2 TGFB2 AR CAV1 BCL2L1 SKP2 LGR5 CCNE1 KRT5 TP63 COL1A2 JAG1 ERBB3 KRT19 ITGB1 CD24 CLDN4 CAV2 EMP1 CDH3 CDH1 PARP2 CCNB1 PROM1 ERBB2 MYCN ESR2 MUC1 PTEN ITGA6 MYLK PGR PLCB4 TP53 Basal/stemlike ( Low enriched) Luminal-like ( High enriched) Intermediate
3 3 SUPPLEMENTARY INFORMATION HCI-002 KIT CCNB1 MUC1 EMP1 CD24 CAV2 ITGB1 CDH1 GATA3 KRT19 PTEN PROM1 CDK1 TP63 ERBB2 PARP2 ERBB3 CLDN4 ERBB1 TP53 CCNE1 MYLK ITGA6 CDH3 COL1A2 NOTCH3 JAG1 PLCB4 ESR2 KRT5 SNAI2 CAV1 AR BCL2L1 SKP2 NOTCH4 BCL2 LGR5 TGFB2 PGR MYCN CD10 Basal/stem-like ( Low enriched) Luminal-like ( High enriched)
4 4 HCI-010 KIT CCNB1 MUC1 EMP1 CD24 CAV2 ITGB1 CDH1 GATA3 KRT19 PTEN PROM1 CDK1 TP63 ERBB2 PARP2 ERBB3 CLDN4 ERBB1 TP53 CCNE1 MYLK ITGA6 CDH3 COL1A2 NOTCH3 JAG1 PLCB4 ESR2 KRT5 SNAI2 CAV1 AR BCL2L1 SKP2 NOTCH4 BCL2 LGR5 TGFB2 PGR MYCN CD10 Basal/stem-like ( Low enriched) Luminal-like ( High enriched) Intermediate
5 HCI #453 (Resected animal) Red = 10.4% Red = 4.2% Luminal-like mets, post-resection (red) = 85.4% Basal/stem-like ( Low enriched) Intermediate Luminal-like ( High enriched) KIT CCNB1 MUC1 EMP1 CD24 CAV2 ITGB1 CDH1 GATA3 KRT19 PTEN PROM1 CDK1 TP63 ERBB2 PARP2 ERBB3 CLDN4 ERBB1 TP53 CCNE1 MYLK ITGA6 CDH3 COL1A2 NOTCH3 JAG1 PLCB4 ESR2 KRT5 SNAI2 CAV1 AR BCL2L1 SKP2 NOTCH4 BCL2 LGR5 TGFB2 PGR MYCN CD10 Clustering by PDX model PDX model HCI-001 HCI-002 HCI-010 CLDN7 CD24 CD44 PARP2 BRCA1 PTEN CD10 THY1 TGFB2 Supplementary Data 2: Full heatmaps showing unsupervised hierarchical clustering analyses shown in Extended Data Fig. 4 Supplementary Data 3: Gene expression in individual lung metastatic cells from each of the 5
6 SUPPLEMENTARY INFORMATION Supplementary Data 3: Gene expression in individual lung metastatic cells from each of the three PDX models (HCI-001, HCI-002, and HCI-010). Box plots show expression levels for each of the 53 genes differentially expressed between the models by Anova. Black dots, single cells; red dots, single cells with no expression. 6
7 DNA damage response and repair Chromatin modification and gene regulation Development and differentiation *NS *NS *NS Cell cycle Other Supplementary Data 4: Gene ontology (GO) enrichment analysis reveals several biological processes are differentially regulated in low-burden metastatic cells. GO enrichment analysis was performed to identify pathways that were more represented in the set of significantly differentially expressed genes than would be expected by chance alone. Pathways involving DNA damage response and repair, chromatic modification and gene regulation, development and differentiation, and cell cycle were identified. p-values are shown at the right of each bar. *NS, not significant. 7
8 SUPPLEMENTARY INFORMATION Supplementary Data 5: Gene expression in individual cells from tissues with low, intermediate, or high metastatic burden. Box plots show expression levels for each differentially expressed gene (p<0.05) in individual cells. P-values and fold change for each gene are shown in Extended Data Table 2. Black dots, single cells; red dots, single cells with no expression. 8
9 Supplementary Data 6: Kaplan-Meier analysis shows the prognostic relevance of 16 genes characteristic of low-burden metastatic cells. The prognostic value of each of the 55 genes characteristic of low-burden metastatic cells (Extended Data Table 2) was determined by Kaplan-Meier analysis using Km-plotter online software. 29 Km plots are shown as probability of distant metastasis-free survival (DMFS). 16 of 55 genes were found to be prognostic: High ACTA2, CHEK1, EPHA4, MYCN, NOTCH3, NOTCH4, SKP2, TGFB1, TGFB2, THY1 and TWIST1 expression was associated with increased risk of distant metastasis, and increased CDH1, ERBB3, MUC1 and PTEN expression was associated with reduced risk of metastasis. 9
10 SUPPLEMENTARY INFORMATION Supplementary Data 7: Gene expression in individual primary tumor cells and metastatic cells from the lung, lymph node, peripheral blood, bone marrow, and brain Supplementary Data 7: Gene expression in individual primary tumor and metastatic cells from the lung, lymph node, peripheral blood, bone marrow, and brain. Box plots show all genes (80) that were significantly differentially expressed (p<0.05, ANOVA) between at least one pair of tissues. The p-value and fold change for each gene and tissue pair and are shown in Supplementary Table 3. Each black dot represents expression in a single cell, and red dots represent non-expressing cells. LU, lung; LN, lymph node; BM, bone marrow; PB, peripheral blood (CTC); BR, brain. 11 Supplementary Data 8: Histogram plots show the distribution of cells yielded following tissue dissociation of lungs and lymph nodes from PDX animals. For consistency, any tissue digests which yielded an abnormal number of cells (>1 standard deviation from the mean) was excluded from the study. This allowed for comparison of the number of metastatic cells in different animals with reasonable consistency. 1 0 W W W. N A T U R E. C O M / N A T U R E
11 Number of animals Lung x = 6.6x10 6-1σ +1σ Number of animals σ Lymph node x = 1.7x σ Total cell number (x10 6 ) Total cell number (x10 6 ) Supplementary Data 8: Histogram plots show the distribution of cells yielded following tissue dissociation of lungs and lymph nodes from PDX animals. For consistency, any tissue digests which yielded an abnormal number of cells (>1 standard deviation from the mean) was excluded from the study. This allowed for comparison of the number of metastatic cells in different animals with reasonable consistency. 11
Supplemental Information. High-Throughput Microfluidic Labyrinth for the. Label-free Isolation of Circulating Tumor Cells
Cell Systems, Volume 5 Supplemental Information High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells Eric Lin, Lianette Rivera-Báez, Shamileh Fouladdel, Hyeun
More informationTitle: Single Cell Dual Adherent-Suspension Co-Culture Micro-Environment for Studying Tumor- Stromal Interactions
Electronic Supplementary Material (ESI) for Lab on a Chip. This journal is The Royal Society of Chemistry 2016 Title: Single Cell Dual Adherent-Suspension Co-Culture Micro-Environment for Studying Tumor-
More informationFigure S1. ERBB3 mrna levels are elevated in Luminal A breast cancers harboring ERBB3
Supplemental Figure Legends. Figure S1. ERBB3 mrna levels are elevated in Luminal A breast cancers harboring ERBB3 ErbB3 gene copy number gain. Supplemental Figure S1. ERBB3 mrna levels are elevated in
More informationIdentifying genomic signatures in circulating breast tumour cells
Identifying genomic signatures in circulating breast tumour cells 9 th ISMRC 2013, Paris, France September 25th, 2013 NISHA KANWAR PhD Candidate Department of Laboratory Medicine and Pathobiology University
More informationGenomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity
Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity Aleix Prat, Barbara Adamo, Cheng Fan, Vicente Peg, Maria Vidal, Patricia Galván, Ana Vivancos, Paolo
More informationThe 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis
The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis Tieliu Shi tlshi@bio.ecnu.edu.cn The Center for bioinformatics
More informationThe Avatar System TM Yields Biologically Relevant Results
Application Note The Avatar System TM Yields Biologically Relevant Results Liquid biopsies stand to revolutionize the cancer field, enabling early detection and noninvasive monitoring of tumors. In the
More informationTEB. Id4 p63 DAPI Merge. Id4 CK8 DAPI Merge
a Duct TEB b Id4 p63 DAPI Merge Id4 CK8 DAPI Merge c d e Supplementary Figure 1. Identification of Id4-positive MECs and characterization of the Comma-D model. (a) IHC analysis of ID4 expression in the
More informationNature Genetics: doi: /ng Supplementary Figure 1. Phenotypic characterization of MES- and ADRN-type cells.
Supplementary Figure 1 Phenotypic characterization of MES- and ADRN-type cells. (a) Bright-field images showing cellular morphology of MES-type (691-MES, 700-MES, 717-MES) and ADRN-type (691-ADRN, 700-
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature10134 Supplementary Figure 1. Anti-inflammatory activity of sfc. a, Autoantibody immune complexes crosslink activating Fc receptors, promoting activation of macrophages, and WWW.NATURE.COM/NATURE
More informationSupplementary. properties of. network types. randomly sampled. subsets (75%
Supplementary Information Gene co-expression network analysis reveals common system-level prognostic genes across cancer types properties of Supplementary Figure 1 The robustness and overlap of prognostic
More informationSUPPLEMENTARY APPENDIX
SUPPLEMENTARY APPENDIX 1) Supplemental Figure 1. Histopathologic Characteristics of the Tumors in the Discovery Cohort 2) Supplemental Figure 2. Incorporation of Normal Epidermal Melanocytic Signature
More informationSupplementary Figure 1. Efficiency of Mll4 deletion and its effect on T cell populations in the periphery. Nature Immunology: doi: /ni.
Supplementary Figure 1 Efficiency of Mll4 deletion and its effect on T cell populations in the periphery. Expression of Mll4 floxed alleles (16-19) in naive CD4 + T cells isolated from lymph nodes and
More informationUC Irvine UC Irvine Previously Published Works
UC Irvine UC Irvine Previously Published Works Title Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells Permalink https://escholarship.org/uc/item/0x8772xv Journal
More informationSupplementary Figure S1 Expression of mir-181b in EOC (A) Kaplan-Meier
Supplementary Figure S1 Expression of mir-181b in EOC (A) Kaplan-Meier curves for progression-free survival (PFS) and overall survival (OS) in a cohort of patients (N=52) with stage III primary ovarian
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature10866 a b 1 2 3 4 5 6 7 Match No Match 1 2 3 4 5 6 7 Turcan et al. Supplementary Fig.1 Concepts mapping H3K27 targets in EF CBX8 targets in EF H3K27 targets in ES SUZ12 targets in ES
More informationTargeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018
Targeted Agent and Profiling Utilization Registry (TAPUR ) Study February 2018 Precision Medicine Therapies designed to target the molecular alteration that aids cancer development 30 TARGET gene alterations
More information(A) Cells grown in monolayer were fixed and stained for surfactant protein-c (SPC,
Supplemental Figure Legends Figure S1. Cell line characterization (A) Cells grown in monolayer were fixed and stained for surfactant protein-c (SPC, green) and co-stained with DAPI to visualize the nuclei.
More informationSUPPLEMENTARY INFORMATION
doi:.38/nature8975 SUPPLEMENTAL TEXT Unique association of HOTAIR with patient outcome To determine whether the expression of other HOX lincrnas in addition to HOTAIR can predict patient outcome, we measured
More informationExpanded View Figures
Molecular Systems iology Tumor CNs reflect metabolic selection Nicholas Graham et al Expanded View Figures Human primary tumors CN CN characterization by unsupervised PC Human Signature Human Signature
More informationSUPPLEMENTARY INFORMATION
DOI: 10.1038/ncb2607 Figure S1 Elf5 loss promotes EMT in mammary epithelium while Elf5 overexpression inhibits TGFβ induced EMT. (a, c) Different confocal slices through the Z stack image. (b, d) 3D rendering
More informationTP53 Mutation, Epithelial-Mesenchymal Transition, and Stemlike Features in Breast Cancer Subtypes
Journal of Biomedicine and Biotechnology Volume 0, Article ID 0, pages doi:0./0/0 Research Article TP Mutation, Epithelial-Mesenchymal Transition, and Stemlike Features in Breast Cancer Subtypes Danila
More informationTable S1: Analysis of Notch gene rearrangements in triple negative breast cancer subtypes
Supplemental Tables Table S1: Analysis of Notch gene rearrangements in triple negative breast cancer subtypes NOTCH1 or NOTCH2 Basal Immune Luminal AR Mesenchymal Stem Like WT 27 (87%) 24 (100%) 4 (66%)
More informationBreast cancer classification: beyond the intrinsic molecular subtypes
Breast cancer classification: beyond the intrinsic molecular subtypes Britta Weigelt, PhD Signal Transduction Laboratory CRUK London Research Institute Summary Breast cancer heterogeneity Molecular classification
More informationPhosphorylation Site Company Cat #
Supplemental Table 1. Antibodies used for RPPA analysis. Label Protein Phosphorylation Site Company Cat # Used on MDA_CLSS Used on MDA_Pilot 4EBP1 4EBP1 Cell Signaling 9452 No 4EBP1.pS65 4EBP1 S65 Cell
More informationSupplementary Figure S1. Gene expression analysis of epidermal marker genes and TP63.
Supplementary Figure Legends Supplementary Figure S1. Gene expression analysis of epidermal marker genes and TP63. A. Screenshot of the UCSC genome browser from normalized RNAPII and RNA-seq ChIP-seq data
More informationSupplementary Figure 1: Comparison of acgh-based and expression-based CNA analysis of tumors from breast cancer GEMMs.
Supplementary Figure 1: Comparison of acgh-based and expression-based CNA analysis of tumors from breast cancer GEMMs. (a) CNA analysis of expression microarray data obtained from 15 tumors in the SV40Tag
More informationNature Immunology: doi: /ni Supplementary Figure 1. Transcriptional program of the TE and MP CD8 + T cell subsets.
Supplementary Figure 1 Transcriptional program of the TE and MP CD8 + T cell subsets. (a) Comparison of gene expression of TE and MP CD8 + T cell subsets by microarray. Genes that are 1.5-fold upregulated
More informationPrognosis for metastatic breast cancer to bones
Prognosis for metastatic breast cancer to bones The Borg System is 100 % Prognosis for metastatic breast cancer to bones Jul 23, 2013. Purpose. Bone is the most frequent site of metastasis among breast
More informationMolecular in vitro diagnostic test for the quantitative detection of the mrna expression of ERBB2, ESR1, PGR and MKI67 in breast cancer tissue.
Innovation for your breast cancer diagnostics PGR G ATA G C G A C G AT C G A A A G A A G T TA G ATA G C G A C G AT C G A A A G A A G T TA G ATA G C G A C G AT C G A A A G A A G T TA G ATA G C G A C ERBB2
More informationSupplementary Figure 1. Characterization of basophils after reconstitution of SCID mice
Supplementary figure legends Supplementary Figure 1. Characterization of after reconstitution of SCID mice with CD4 + CD62L + T cells. (A-C) SCID mice (n = 6 / group) were reconstituted with 2 x 1 6 CD4
More informationEarly dissemination in prostate cancer
Early dissemination in prostate cancer Miodrag Guzvic, University of Regensburg, Germany Adjuvant Palliative M0 Initiation Diagnosis Surgery Metastasis Death Intervention window to delay or prevent metastasis
More informationSupplementary Figure 1 ITGB1 and ITGA11 increase with evidence for heterodimers following HSC activation. (a) Time course of rat HSC activation
Supplementary Figure 1 ITGB1 and ITGA11 increase with evidence for heterodimers following HSC activation. (a) Time course of rat HSC activation indicated by the detection of -SMA and COL1 (log scale).
More informationRecent advances in breast cancers
Recent advances in breast cancers Breast cancer is a hetrogenous disease due to distinct genetic alterations. Similar morphological subtypes show variation in clinical behaviour especially in response
More informationContemporary Classification of Breast Cancer
Contemporary Classification of Breast Cancer Laura C. Collins, M.D. Vice Chair of Anatomic Pathology Professor of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Outline
More informationMorphological and Molecular Typing of breast Cancer
Morphological and Molecular Typing of breast Cancer Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology, Nottingham University Hospitals NHS Trust Histological
More informationSupplementary Table 1: List of the 242 hypoxia/reoxygenation marker genes collected from literature and databases
Supplementary Tables: Supplementary Table 1: List of the 242 hypoxia/reoxygenation marker genes collected from literature and databases Supplementary Table 2: Contingency tables used in the fisher exact
More informationExpression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer
Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer R. Joseph Bender, Feilim Mac Gabhann* Institute for Computational Medicine and Department of Biomedical Engineering,
More informationPatient characteristics of training and validation set. Patient selection and inclusion overview can be found in Supp Data 9. Training set (103)
Roepman P, et al. An immune response enriched 72-gene prognostic profile for early stage Non-Small- Supplementary Data 1. Patient characteristics of training and validation set. Patient selection and inclusion
More informationCarcinome du sein Biologie moléculaire. Thomas McKee Service de Pathologie Clinique Genève
Carcinome du sein Biologie moléculaire Thomas McKee Service de Pathologie Clinique Genève Pathology Diagnostic Prognostic information Predictive information The information provided depends on the available
More informationGene Signatures in Breast Cancer: Moving Beyond ER, PR, and HER2? Lisa A. Carey, M.D. University of North Carolina USA
Gene Signatures in Breast Cancer: Moving Beyond ER, PR, and HER2? Lisa A. Carey, M.D. University of North Carolina USA When Are Biomarkers Ready To Use? Same Rules for Gene Expression Panels Key elements
More informationMaram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine
Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine The most common non-skin malignancy of women 2 nd most common cause of cancer deaths in women, following
More informationSUPPLEMENTARY INFORMATION
DOI: 1.138/ncb3355 a S1A8 + cells/ total.1.8.6.4.2 b S1A8/?-Actin c % T-cell proliferation 3 25 2 15 1 5 T cells Supplementary Figure 1 Inter-tumoral heterogeneity of MDSC accumulation in mammary tumor
More informationProteomic Biomarker Discovery in Breast Cancer
Proteomic Biomarker Discovery in Breast Cancer Rob Baxter Laboratory for Cellular and Diagnostic Proteomics Kolling Institute, University of Sydney, Royal North Shore Hospital robert.baxter@sydney.edu.au
More informationImpact of Prognostic Factors
Melanoma Prognostic Factors: where we started, where are we going? Impact of Prognostic Factors Staging Management Surgical intervention Adjuvant treatment Suraj Venna, MD Assistant Clinical Professor,
More informationNature Methods: doi: /nmeth Supplementary Figure 1
Supplementary Figure 1 Finite-element analysis of cell cluster dynamics in different cluster trap architectures. (a) Cluster-Chip (b) Filter (c) A structure identical to the Cluster-Chip except that one
More informationHER2-Targeted Rx. An Historical Perspective
HER2-Targeted Rx An Historical Perspective Trastuzumab: Front Line Rx for MBC Median 20.3 v. 25.1 mo P = 0.046 HR 0.8 65% of control patients crossed over Slamon D, et al. N Engl J Med, 2001; 344:783 Trastuzumab:Front-line
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature12215 Supplementary Figure 1. The effects of full and dissociated GR agonists in supporting BFU-E self-renewal divisions. BFU-Es were cultured in self-renewal medium with indicated GR
More informationComputer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015
Goals/Expectations Computer Science, Biology, and Biomedical (CoSBBI) We want to excite you about the world of computer science, biology, and biomedical informatics. Experience what it is like to be a
More informationSesiones interhospitalarias de cáncer de mama. Revisión bibliográfica 4º trimestre 2015
Sesiones interhospitalarias de cáncer de mama Revisión bibliográfica 4º trimestre 2015 Selected papers Prospective Validation of a 21-Gene Expression Assay in Breast Cancer TAILORx. NEJM 2015 OS for fulvestrant
More informationMolecular in vitro diagnostic test for the quantitative detection of the mrna expression of ERBB2, ESR1, PGR and MKI67 in breast cancer tissue.
Innovation for your breast cancer diagnostics Now valid ated on: -Roche cob as z 480 A nalyzer -Roche L ightcycle r 480 II - ABI 750 0 Fast -Versant kpcr Cyc ler PGR ESR1 MKI67 Molecular in vitro diagnostic
More informationGenomic Medicine: What every pathologist needs to know
Genomic Medicine: What every pathologist needs to know Stephen P. Ethier, Ph.D. Professor, Department of Pathology and Laboratory Medicine, MUSC Director, MUSC Center for Genomic Medicine Genomics and
More informationFISH mcgh Karyotyping ISH RT-PCR. Expression arrays RNA. Tissue microarrays Protein arrays MS. Protein IHC
Classification of Breast Cancer in the Molecular Era Susan J. Done University Health Network, Toronto Why classify? Prognosis Prediction of response to therapy Pathogenesis Invasive breast cancer can have
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature13173 Supplementary Table 1. List of genes commonly expressed in all single cells. Name Actb Actin, beta, cytoplasmic Actg1 Actin, gamma, cytoplasmic 1 Atp5e ATP synthase, H+ transporting,
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationAssessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18
Assessment and Management of Genetic Predisposition to Breast Cancer Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18 Overview The role of the Cancer Genetics team NICE guidelines for Familial Breast
More informationMolecular Enhancement of Sentinel Node Evaluation
Cochran Illustrations 060104 Molecular Enhancement of Sentinel Node Evaluation Alistair Cochran, MD and Rong Huang MD Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of
More informationNature Immunology: doi: /ni Supplementary Figure 1. Huwe1 has high expression in HSCs and is necessary for quiescence.
Supplementary Figure 1 Huwe1 has high expression in HSCs and is necessary for quiescence. (a) Heat map visualizing expression of genes with a known function in ubiquitin-mediated proteolysis (KEGG: Ubiquitin
More informationComparison of prognostic signatures for ER positive breast cancer in TransATAC:
Comparison of prognostic signatures for ER positive breast cancer in TransATAC: EndoPredict, a high performance test in node negative and node positive disease Ivana Sestak, PhD Centre for Cancer Prevention
More informationSupplementary Information
Supplementary Information Prognostic Impact of Signet Ring Cell Type in Node Negative Gastric Cancer Pengfei Kong1,4,Ruiyan Wu1,Chenlu Yang1,3,Jianjun Liu1,2,Shangxiang Chen1,2, Xuechao Liu1,2, Minting
More informationstomach p63/krt5 CDH17 CEACAM5 CEACAM7 ANXA13 ANXA10 CLDN18 VSIG1 TFF2 VIL1 GDA
Supplementary Fig. 1 a esophagus Barrett s e FABP1 Ecad stomach TFF3 b p63/krt5 CDH17 REG4 CDH17 f c signal intensity p63/krt5 EsoSC 5000 4000 3000 2000 CDH17 1500 1000 Barrett s KRT14 KRT6A KRT13 KRT5
More informationTable S2. Expression of PRMT7 in clinical breast carcinoma samples
Table S2. Expression of PRMT7 in clinical breast carcinoma samples (All data were obtained from cancer microarray database Oncomine.) Analysis type* Analysis Class(number sampels) 1 2 3 4 Correlation (up/down)#
More informationMolecular classification of breast cancer implications for pathologists. Sarah E Pinder
Molecular classification of breast cancer implications for pathologists Sarah E Pinder Courtesy of CW Elston Histological types Breast Cancer Special Types 17 morphological special types 25-30% of all
More informationIdentification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Research article Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Brian D. Lehmann, 1 Joshua A. Bauer, 1 Xi Chen, 2 Melinda E. Sanders,
More informationCancer cells in vitro
Supplementary Figure S1 Cancer cells in vitro Pretreatment with Control IgG (18h) Pretreatment with anti-u-par (18h) Acid Wash/Pretreatment with Control IgG (18h) Acid Wash/Pretreatment with anti-u-par
More informationTranscriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival -- Evidence from TCGA Pan-Cancer Data
Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival -- Evidence from TCGA Pan-Cancer Data Supplementary Materials Xiu Huang, David Stern, and
More informationIdentifying transcriptional dichotomies by "stochastic sampling"
Identifying transcriptional dichotomies by "stochastic sampling" Kevin Janes and Joan Brugge Department of Cell Biology Harvard Medical School pakt (S473) keratin 10 DAPI National Cancer Institute (CA105134)
More informationModels of cell signalling uncover molecular mechanisms of high-risk neuroblastoma and predict outcome
Models of cell signalling uncover molecular mechanisms of high-risk neuroblastoma and predict outcome Marta R. Hidalgo 1, Alicia Amadoz 2, Cankut Çubuk 1, José Carbonell-Caballero 2 and Joaquín Dopazo
More informationJournal: Nature Methods
Journal: Nature Methods Article Title: Network-based stratification of tumor mutations Corresponding Author: Trey Ideker Supplementary Item Supplementary Figure 1 Supplementary Figure 2 Supplementary Figure
More informationEvaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value
Lehmann et al. BMC Cancer (2015) 15:179 DOI 10.1186/s12885-015-1102-7 RESEARCH ARTICLE Open Access Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic
More informationBreast Cancer: ASCO Poster Review
Breast Cancer: ASCO Poster Review Carmen Criscitiello, MD, PhD Istituto Europeo di Oncologia Milano HER2+ SUBTYPE Research questions in early HER2+ BC De-escalation of toxicity without compromising efficacy
More informationModern classification of breast cancer-should we stick with morphology or convert to molecular profiles?
Modern classification of breast cancer-should we stick with morphology or convert to molecular profiles? Ian Ellis Professor of Cancer Pathology Molecular Medical Sciences University of Nottingham Dept
More informationSupplementary Tables. Supplementary Figures
Supplementary Files for Zehir, Benayed et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients Supplementary Tables Supplementary Table 1: Sample
More informationPlasma-Seq conducted with blood from male individuals without cancer.
Supplementary Figures Supplementary Figure 1 Plasma-Seq conducted with blood from male individuals without cancer. Copy number patterns established from plasma samples of male individuals without cancer
More informationComparative study of multicellular tumor spheroid formation methods and implications for drug screening
Supporting Information Comparative study of multicellular tumor spheroid formation methods and implications for drug screening Maria F. Gencoglu, Lauren E. Barney, Christopher L. Hall, Elizabeth A. Brooks,
More informationSureSelect Cancer All-In-One Custom and Catalog NGS Assays
SureSelect Cancer All-In-One Custom and Catalog NGS Assays Detect all cancer-relevant variants in a single SureSelect assay SNV Indel TL SNV Indel TL Single DNA input Single AIO assay Single data analysis
More informationThe Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer
Welcome! The Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer Prof. Sabine Kasimir-Bauer Department of Gynecology and Obstetrics University Hospital
More informationSupplementary Materials for
www.sciencetranslationalmedicine.org/cgi/content/full/7/283/283ra54/dc1 Supplementary Materials for Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
More informationShould we still be performing IHC on all sentinel nodes?
Miami Breast Cancer Conference 31 st Annual Conference March 8, 2014 Should we still be performing IHC on all sentinel nodes? Donald L. Weaver, MD Professor of Pathology University of Vermont USA Miami
More informationSupplementary Figures
Supplementary Figures Supplementary Fig. 1. Galectin-3 is present within tumors. (A) mrna expression levels of Lgals3 (galectin-3) and Lgals8 (galectin-8) in the four classes of cell lines as determined
More informationSupplementary Figure 1: Experimental design. DISCOVERY PHASE VALIDATION PHASE (N = 88) (N = 20) Healthy = 20. Healthy = 6. Endometriosis = 33
DISCOVERY PHASE (N = 20) Healthy = 6 Endometriosis = 7 EAOC = 7 Quantitative PCR (mirnas = 1113) a Quantitative PCR Verification of Candidate mirnas (N = 24) VALIDATION PHASE (N = 88) Healthy = 20 Endometriosis
More informationExpanded View Figures
EMO Molecular Medicine Proteomic map of squamous cell carcinomas Hanibal ohnenberger et al Expanded View Figures Figure EV1. Technical reproducibility. Pearson s correlation analysis of normalised SILC
More informationBreast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment?
Breast Cancer Breast Cancer Excess Estrogen Exposure Nulliparity or late pregnancy + Early menarche + Late menopause + Cystic ovarian disease + External estrogens exposure + Breast Cancer Excess Estrogen
More informationRelationship between genomic features and distributions of RS1 and RS3 rearrangements in breast cancer genomes.
Supplementary Figure 1 Relationship between genomic features and distributions of RS1 and RS3 rearrangements in breast cancer genomes. (a,b) Values of coefficients associated with genomic features, separately
More informationand follicular helper T cells is Egr2-dependent. (a) Diagrammatic representation of the
Supplementary Figure 1. LAG3 + Treg-mediated regulation of germinal center B cells and follicular helper T cells is Egr2-dependent. (a) Diagrammatic representation of the experimental protocol for the
More informationAJCC TNM STAGING UPDATES ARE YOU READY FOR TNM?
AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM? FCRA Annual Conference Boca Raton, Florida 7/26/2016 Steven Peace, CTR 1 Introduction Order AJCC Cancer Staging Manual, 7 th ed. How To Use - AJCC Cancer
More informationUnravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
ARTICLE DOI:.8/s67-8-6- OPEN Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq 6789():,; Mihriban Karaayvaz, Simona Cristea,,, Shawn M. Gillespie,, Anoop
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature10188 Supplementary Figure 1. Embryonic epicardial genes are down-regulated from midgestation stages and barely detectable post-natally. Real time qrt-pcr revealed a significant down-regulation
More informationDr David Guttery Senior PDRA Dept. of Cancer Studies and CRUK Leicester Centre University of Leicester
Dr David Guttery Senior PDRA Dept. of Cancer Studies and CRUK Leicester Centre University of Leicester dsg6@le.ac.uk CFDNA/CTDNA Circulating-free AS A LIQUID DNA BIOPSY (cfdna) Tumour Biopsy Liquid Biopsy
More information* * * * Supplementary Figure 1. DS Lv CK HSA CK HSA. CK Col-3. CK Col-3. See overleaf for figure legend. Cancer cells
Supplementary Figure 1 Cancer cells Desmoplastic stroma Hepatocytes Pre-existing sinusoidal blood vessel New blood vessel a Normal liver b Desmoplastic HGP c Pushing HGP d Replacement HGP e f g h i DS
More informationThe Center for PERSONALIZED DIAGNOSTICS
The Center for PERSONALIZED DIAGNOSTICS Precision Diagnostics for Personalized Medicine A joint initiative between The Department of Pathology and Laboratory Medicine & The Abramson Cancer Center The (CPD)
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationNature Medicine: doi: /nm.3967
Supplementary Figure 1. Network clustering. (a) Clustering performance as a function of inflation factor. The grey curve shows the median weighted Silhouette widths for varying inflation factors (f [1.6,
More informationSCATTER PLOTS AND TREND LINES
1 SCATTER PLOTS AND TREND LINES LEARNING MAP INFORMATION STANDARDS 8.SP.1 Construct and interpret scatter s for measurement to investigate patterns of between two quantities. Describe patterns such as
More informationWHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.
WHAT IS A GENE? CHROMOSOME E GEN DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE
More informationPROSTATE CANCER HORMONE THERAPY AND BEYOND. Przemyslaw Twardowski MD Professor of Oncology Department of Urologic Oncology John Wayne Cancer Institute
PROSTATE CANCER HORMONE THERAPY AND BEYOND Przemyslaw Twardowski MD Professor of Oncology Department of Urologic Oncology John Wayne Cancer Institute Disclosures I am a Consultant for Bayer and Sanofi-Aventis
More informationENFERMEDAD AVANZADA Qué hacemos con el triple negativo? Nuevas aproximaciones
ENFERMEDAD AVANZADA Qué hacemos con el triple negativo? Nuevas aproximaciones Javier Cortes, Hospital Universitario Ramon y Cajal, Madrid Vall d Hebron Institute of Oncology (VHIO), Barcelona Triple Negative
More informationResearch Article Breast Cancer Prognosis Risk Estimation Using Integrated Gene Expression and Clinical Data
BioMed Research International, Article ID 459203, 15 pages http://dx.doi.org/10.1155/2014/459203 Research Article Breast Cancer Prognosis Risk Estimation Using Integrated Gene Expression and Clinical Data
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION Frampton et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing Supplementary Figure 1A Base substitution detection
More information